LIVN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LIVN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, LivaNova's Trailing 12-Month Free Cash Flow is $85 Mil, and Market Cap is $2,803 Mil. Therefore, LivaNova's FCF Yield % for today is 3.04%.
The historical rank and industry rank for LivaNova's FCF Yield % or its related term are showing as below:
During the past 13 years, the highest FCF Yield % of LivaNova was 5.80%. The lowest was -11.23%. And the median was 1.67%.
LivaNova's FCF Margin % for the quarter that ended in Sep. 2024 was 10.32%.
The historical data trend for LivaNova's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova Annual Data | |||||||||||||||||||||
Trend | Apr14 | Apr15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
FCF Yield % | Get a 7-Day Free Trial | -3.17 | -3.55 | 1.65 | 1.46 | 1.43 |
LivaNova Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
FCF Yield % | Get a 7-Day Free Trial | 1.32 | 5.88 | 0.48 | 4.18 | - |
For the Medical Devices subindustry, LivaNova's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's FCF Yield % distribution charts can be found below:
* The bar in red indicates where LivaNova's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
LivaNova's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | 39.933 | / | 2789.727668 | |
= | 1.43% |
LivaNova's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | 32.817 | * | 4 | / | 0 | |
= | N/A% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of LivaNova's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Francesco Bianchi | director | C/O LIVANOVA PLC, 5 MERCHANT SQUARE, LONDON X0 W2 1AY |
Daniel Jeffrey Moore | director | 100 CYBERONICS BVLD, HOUSTON TX 77058 |
James Christopher Barry | director | 7475 LUSK BLVD, SAN DIEGO CA 92121 |
Damien Mcdonald | officer: COO | 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY |
Michael Damon Hutchinson | officer: Chief Legal Officer | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Brooke Story | director | C/O SIGILON THERAPEUTICS, INC., 100 BINNEY STREET, SUITE 600, CAMBRIDGE MA 02142 |
Peter M Wilver | director | |
Alfred J Novak | director | 325 NE 6TH ST, BOCA RATON FL 33432 |
William A Kozy | director | C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417 |
Marco Dolci | officer: SVP Global Operations, R&D | VIA BENIGNO CRESPI 17, MILAN L6 20159 |
Todd C Schermerhorn | director | C/O C.R BARD INC, 730 CENTRAL AVE, MURRAY HILL NJ 07974 |
Alex Shvartsburg | officer: Interim CFO | 20 EASTBOURNE TERRACE, LONDON X0 W26LG |
Roy Khoury | officer: President, International | 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON X0 W21AY |
Thad Allen Huston | officer: Chief Financial Officer | 941 BLOOMFIELD ST, HOBOKEN NJ 07030 |
Seng Stacy Enxing | director | C/O HILL-ROM HOLDINGS, INC., SUITE 4100 180 NORTH STETSON AVENUE, CHICAGO IL 60601 |
From GuruFocus
By PRNewswire • 06-24-2024
By Marketwired • 06-22-2024
By PRNewswire • 07-19-2024
By GuruFocus Research • 05-01-2024
By GuruFocus Research • 07-31-2024
By Business Wire • 04-25-2024
By GuruFocus Research • 05-01-2024
By Business Wire • 03-06-2024
By Business Wire • 08-19-2024
By Marketwired • 07-20-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.